The Sensitivity and Specificity of Novel Primers for Detection of BRAF(V600E) Mutation

por Tayeb, Bizhar A, Pringle, Howard J
Publicado no Asian Pac J Cancer Prev (2020)

Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery

por Powley, Ian R., Patel, Meeta, Miles, Gareth, Pringle, Howard, Howells, Lynne, Thomas, Anne, Kettleborough, Catherine, Bryans, Justin, Hammonds, Tim, MacFarlane, Marion, Pritchard, Catrin
Publicado no Br J Cancer (2020)

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity

por Myint, Ni Ni Moe, Verma, Ajay M., Fernandez-Garcia, Daniel, Sarmah, Panchali, Tarpey, Patrick S., Al-Aqbi, Saif Sattar, Cai, Hong, Trigg, Ricky, West, Kevin, Howells, Lynne M., Thomas, Anne, Brown, Karen, Guttery, David S., Singh, Baljit, Pringle, Howard J., McDermott, Ultan, Shaw, Jacqui A., Rufini, Alessandro
Publicado no Cell Death Dis (2018)